Editorial overview: Endocrine and metabolic diseases (2023)
Current Opinion in Pharmacology · 2024
DOI: 10.1016/j.coph.2024.102436 ↗Kurz gefasst
Editorial in der Zeitschrift Current Opinion in Pharmacology, 2024. Verfasst von Ivana Bjelobaba und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biological Research "Siniša Stanković", National Institute of Republic of Serbia, University of Belgrade, Serbia. Electronic address: iv…. Hauptthemen laut MEDLINE: Metabolic Diseases, Endocrine System Diseases. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Biological Research "Siniša Stanković", National Institute of Republic of Serbia, University of Belgrade, Serbia. Electronic address: ivana.bjelobaba@ibiss.bg.ac.rs.
- National Institute of Child Health and Human Development, National Institute of Health, Bethesda, MD, United States. Electronic address: stephanie.constantin@nih.gov.
Zitieren
APA
Bjelobaba, I., & Constantin, S. (2024). Editorial overview: Endocrine and metabolic diseases (2023). Current Opinion in Pharmacology. https://doi.org/10.1016/j.coph.2024.102436
Vancouver
Bjelobaba I, Constantin S. Editorial overview: Endocrine and metabolic diseases (2023). Current Opinion in Pharmacology. 2024. doi:10.1016/j.coph.2024.102436
BibTeX
@article{Bjelobaba2024,
author = {Bjelobaba, Ivana and Constantin, Stephanie},
title = {Editorial overview: Endocrine and metabolic diseases (2023)},
journal = {Current Opinion in Pharmacology},
year = {2024},
doi = {10.1016/j.coph.2024.102436}
}
EUVIMED